Table 1:

Clinical and demographic patient characteristics by symptom-to-MRI time and the presence of FVH^{^a}

Characteristics	Group 1 (n = 191)			Group 2 (n = 164)			Group 3 (n = 104)
Characteristics	FVH (−) (n = 74)	FVH (+) (n = 117)	P Value	FVH (−) (n = 63)	FVH (+) (n = 101)	P Value	FVH (−) (n = 44)	FVH (+) (n = 60)	P Value
Women	27 (36.5)	37 (31.6)	.53	20 (31.7)	27 (26.7)	.60	10 (22.7)	20 (33.3)	.28
Age (yr)	60.7 ± 14.3	63.9 ± 12.5	.11	66 (46–73)	65.5 (54–74)	.88	55.1 ± 13.7	63.6 ± 11.0	.001^{^b}
Symptom-to-admission time (days)	3 (2–4)	2 (1–4)	.05	5 (4–7)	4 (3–7)	.21	16.5 (12–31)	19.5 (12–30.75)	.79
Risk factors
Hypertension	58 (78.4)	82 (70.1)	.24	35 (55.6)	70 (69.3)	.09	31 (70.5)	45 (75)	.66
Diabetes mellitus	29 (39.2)	28 (23.9)	.03^{^b}	16 (25.4)	36 (35.6)	.23	12 (27.3)	13 (21.7)	.64
Hypercholesterolemia	24 (32.4)	43 (36.8)	.64	24 (38.1)	30 (29.7)	.31	8 (18.2)	8 (13.3)	.59
Smoker	24 (32.4)	52 (44.4)	.13	25 (39.7)	48 (47.5)	.34	19 (43.2)	26 (43.3)	1.00
Coronary heart disease	5 (6.8)	6 (5.1)	.88	1 (1.6)	6 (5.9)	.35	6 (13.6)	5 (8.3)	.59
Atrial fibrillation	4 (5.4)	8 (6.8)	.93	2 (3.2)	1 (1.0)	.88	1 (2.3)	2 (3.3)	1.00
Previous stroke	18 (24.3)	29 (24.8)	1.00	9 (14.3)	25 (24.8)	.12	9 (20.5)	19 (31.7)	.27
NIHSS score at admission	4 (2–7)	6 (3–10)	.02^{^b}	4 (2–9)	5 (2–9)	.32	5 (2–10)	4.5 (2–9)	.56
Hospitalization (days)	10.5 (8–13)	13 (10–16)	.001^{^b}	12 (9–15)	13 (9–15)	.95	13.5 (8–15)	12.5 (9.25–16)	.94
Outcome at discharge
mRS	2 (1–3)	3 (2–4)	<.001^{^b}	2 (1–3)	3 (2–4)	.10	2.5 (1–4)	3 (1.25–4)	.54
mRS ≥ 2	54 (73.0)	100 (85.5)	.04^{^b}	43 (68.3)	85 (84.2)	.02^{^b}	31 (70.5)	45 (75.0)	.66
mRS ≥ 3	31 (41.9)	70 (59.8)	.02^{^b}	29 (46.0)	52 (51.5)	.52	22 (50.0)	34 (56.7)	.55